D. J. Betteridge - Concepedia

Author

D. J. Betteridge

Also Known As

Betteridge D., D BETTERIDGE, D Betteridge, D J B Betteridge, D J Betteridge, D John Betteridge, D John Betteridge (deceased), D. Betteridge, D. J. BETTERIDGE, D. J. Betteridge

203

Publications

15.4K

Citations

H-Index

Concepts

All Affiliations

University College London The Royal Free Hospital University of Manchester University of Oxford University College Hospital

About

D. J. Betteridge is an author at University College London specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	45	4K
2	Health Sciences	19	21	2.3K
3	Public Health	17	20	4.8K
4	Engineering	1	1	27
5	Social Sciences	1	1	28

D. J. Betteridge

Publications

10.6K

Citations

H-Index

Page 1

	Year	Citations
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington, The Lancet Metabolic SyndromePrimary PreventionDiabetes ManagementHealth PolicyCardiovascular Disease	2004	3.8K
Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge, Stroke	2007	473
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome Gerard S. Conway, Rajendra Agrawal, D. J. Betteridge, Clinical Endocrinology	1992	426
Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels Peter Clarkson, David S. Celermajer, Ann E. Donald, Journal of the American College of Cardiology Metabolic SyndromeDisease DurationCardiovascular DiseaseMedicinePhysiology	1996	420
Plasma 8‐epi‐PGF<sub>2α</sub> levels are elevated in individuals with non‐insulin dependent diabetes mellitus N.K. Gopaul, Erik Änggård, Anthony I. Mallet, FEBS Letters Lipid PeroxidationPathologyPlasma 8‐Epi‐pgfInsulin SignalingRedox Biology	1995	390
Relationships between plasma measures of oxidative stress and metabolic control in NIDDM Jaffar Nourooz‐Zadeh, A. Rahimi, Jarad TAJADDINI-SARMADI, Diabetologia Metabolic SyndromePlasma MeasuresBiochemistryReactive Nitrogen SpecieLipid Peroxidation	1997	305
Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. G. A. Oswald, C. C. T. Smith, D. J. Betteridge, BMJ Heart FailureHyperlipidemiaPlasma Glucose ConcentrationAcute Myocardial InfarctionMetabolic Syndrome	1986	269
Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS) Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington, American Journal of Kidney Diseases Metabolic SyndromeHemodialysisUrologyRenal FunctionHealth Policy	2009	252
Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe Anne Katrin Sjølie, Judith Stephenson, S J Aldington, Ophthalmology Diabetic RetinopathyOcular DiseaseOphthalmologyDiabetesEye Tracking	1997	216
Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. Roy J. Soberman, Timothy W. Harper, D. J. Betteridge, Journal of Biological Chemistry InflammationLipid AnalysisOxysterolBiochemistryOmega-3 Fatty Acid	1985	178

Page 1